VEGFA and macular retinal edema: The FALCON trial will investigate how to optimally initiate a switch to brolucizumab treatment after an unsatisfactory anti-VEGF treatment response including recurrent or recalcitrant macular edema and assesses treatment initiation with an anti-VEGF in a switch situation with or without loading dose.